DKP Critical Insights® Syndicated Reports
DKP has developed a series of syndicated reports to provide perspectives into the oncology and rare-disease environment. The reports are designed to help you inform short- and long-term strategies that will support market positioning of your portfolio, as well as ongoing patient access to care.
State Cancer Coverage Acts and Legislation
Click here for more information
- Clarify “cancer drug coverage” and “coverage for off-label indications” provisions within state legislation
- Identify definition of and application for clinical compendia provisions
- Determine geographic variation in legislative content
- Understand how legislative provisions such as these can trump payer-based oncology drug coverage/utilization management